EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017 · DOI: 10.3892/etm.2017.4939 · Published: January 1, 2017
Spinal cord injury can result in the loss of motor or sensory neurons. Stem cell therapies promote neuronal regeneration following SCI, by releasing trophic factors or by differentiating into neurons or glial cells to replace damaged cells. Scaffolds support cell survival, proliferation, and differentiation in vivo by mimicking a favorable microenvironment. Combining engineered scaffolds with stem cells is a promising strategy for encouraging spinal cord regeneration. The review focuses on the regenerative potential of mesenchymal stem cells from different sources combined with various scaffold types in preclinical and clinical SCI studies.
Combining MSCs with scaffolds can improve cell survival, migration, and differentiation, leading to better SCI regeneration and functional recovery.
Engineered scaffolds can mimic a favorable microenvironment, stimulating endogenous repair mechanisms in the injured spinal cord.
Clinical trials show promise for using MSC-seeded scaffolds for nerve regeneration and functional recovery in SCI patients, though more evidence is needed.